National Institute of Allergy and Infectious Diseases (NIAID)

🚀 Dreaming of a career where you can make a difference? Discover the endless possibilities at NIAID with our #recruitment video. Whether you’re passionate about science, administration, or innovation, there is a place for you. Learn more from some of the dedicated public servants who make NIAID a great place to work: https://lnkd.in/e-sD2kX5 #PSRW #NIAIDCareers

Do you perform antimicrobial resistance (AMR) research, or would you like to join a team to work on microbial and AMR data analysis? Join NCBI & the National Institute of Allergy and Infectious Diseases (NIAID) BioIT for a virtual codeathon, Resistance is Futile: A codeathon to combat antimicrobial resistance, Sept 23-27, 2024. Apply by July 28: https://ow.ly/UgXB50RYbpe

Feeding children peanut products regularly from infancy to age 5 years reduced the rate of #PeanutAllergy in adolescence by 71%, even when the children ate or avoided #peanut products as desired for many years. These new findings from an #NIAID-sponsored study provide conclusive evidence that achieving long-term prevention of peanut allergy is possible through early allergen consumption. Learn more: https://go.nih.gov/1AwtQon #FoodAllergy #allergy #allergic #NIH King's College London NEJM Evidence

A #NIAID-supported analysis found that opportunistic infection-related hospitalizations and in-hospital mortality rates in the United States were higher among people with #HIV who had limited access to care, among other factors. The authors suggest that opportunistic infections can be prevented and their outcomes can be improved by increasing health insurance coverage, providing differentiated HIV care for certain subgroups, re-evaluating opportunistic infection prevention guidelines, and increasing the workforce of HIV specialists. Learn more: https://lnkd.in/e5HhTkkH University of Virginia

A new NIAID-funded study published today in the NEJM found mice given raw milk samples from dairy cows infected with H5N1 influenza experienced high virus levels in their respiratory organs, suggesting H5N1 risk for animals consuming raw milk and questions of potential risk for people. Link: https://go.nih.gov/Xgjf6pl

The Legislative Affairs and Correspondence Management Branch in the Office of Communications and Government Relations (OCGR) at #NIAID seeks a highly skilled individual with the ability to conduct analyses of scientific programs and policies for a scientific information analyst position. OCGR values coordination across all NIAID Divisions and NIH – working together as a team to provide support to accomplish NIAID’s scientific mission. Applications open 6/03 and close 6/07. Learn more about the position at https://go.nih.gov/iRFGey1 #NIAIDCareers #NIH

A #NIAID-funded animal study found that a nanofluidic controlled release device delivered #HIV therapy with more antiviral potency than when the same medicine was provided orally on a daily or weekly basis. Learn more: https://lnkd.in/dhSiakV9 #ART

An #HIV #vaccine candidate elicited trace levels of HIV broadly neutralizing #antibodies and high levels of other key immune cells in a #NIAID-sponsored early-stage clinical trial. This immune response is an important signal that, if antibody levels can be further amplified, the vaccination strategy might be able to prevent HIV. The findings of this #NIAID-supported trial were published in the journal Cell. Learn more: https://go.nih.gov/M9FYtpT The Duke Human Vaccine Institute Fred Hutch Bill & Melinda Gates Foundation Cell Press #bNAbs #NIH

Since the peak of a global #mpox outbreak in the summer of 2022, infections have thankfully decreased. Yet mpox remains a public health threat, and no treatment has been proven safe and effective for people experiencing mpox disease. However, scientists are on the case—and you may be able to help! Read the full article for more details.

Join us on May 28-29 for the "AI and Immunology: Exploring Opportunities and Challenges" symposium. In this hybrid event, join leading experts in #ArtificialIntelligence (AI) and immunology to discuss the integration of AI in understanding #immunological data and identify existing resources, needs, and future scientific and clinical opportunities with AI. Learn more at https://go.nih.gov/FDcCcYp